.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Ethinyl estradiol; norethindrone - Generic Drug Details

« Back to Dashboard
Ethinyl estradiol; norethindrone is the generic ingredient in ninety-eight branded drugs marketed by Ortho Mcneil Pharm, Novast Labs Ltd, Jai Pharma Ltd, Lupin Ltd, Vintage Pharms, Warner Chilcott Llc, Janssen Pharms, Watson Labs, Warner Chilcott, Glenmark Generics, Vintage Pharms Llc, Barr, LPI, Allergan Sales Llc, Ortho Mcneil Janssen, Apil, Mayne Pharma, Amneal Pharms, Barr Labs Inc, Parke Davis, Glenmark Pharms Ltd, and Lupin Atlantis, and is included in one hundred and seventeen NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for ethinyl estradiol; norethindrone. Twenty suppliers are listed for this compound.

Summary for Generic Name: ethinyl estradiol; norethindrone

Tradenames:98
Patents:3
Applicants:22
NDAs:117
Drug Master File Entries: see list26
Suppliers / Packaging: see list20
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: ethinyl estradiol; norethindrone

Clinical Trials for: ethinyl estradiol; norethindrone

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apil
MINASTRIN 24 FE
ethinyl estradiol; norethindrone acetate
TABLET, CHEWABLE;ORAL203667-001May 8, 2013RXYes6,667,050Apr 6, 2019Y
Novast Labs Ltd
LERIBANE
ethinyl estradiol; norethindrone acetate
TABLET;ORAL203435-002Jun 3, 2016RXNo
Jai Pharma Ltd
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ethinyl estradiol; norethindrone acetate
TABLET;ORAL205049-001May 31, 2016RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ethinyl estradiol; norethindrone

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ethinyl estradiol; norethindrone
TABLET, CHEWABLE;ORAL022573-001Dec 22, 20105,552,394<disabled>
Janssen Pharms
ORTHO-NOVUM 7/7/7-21
ethinyl estradiol; norethindrone
TABLET;ORAL-21018985-001Apr 4, 19844,544,554<disabled>
Janssen Pharms
ORTHO-NOVUM 7/7/7-21
ethinyl estradiol; norethindrone
TABLET;ORAL-21018985-001Apr 4, 19844,530,839<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc